Literature DB >> 14672109

A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes.

Sheri L Maddigan1, David H Feeny, Jeffrey A Johnson.   

Abstract

PURPOSE: Past research into health-related quality of life (HRQL) in diabetes using preference-based measures, such as the Health Utilities Index Mark 2 (HUI2) or the Health Utilities Index Mark 3 (HUI3), is sparse. Important differences between the HUI2 and HUI3 could lead to differences in their abilities to capture HRQL deficits in type 2 diabetes. This analysis compared the extent to which the HUI2 and HUI3 detect differences associated with varying levels of disease severity or advancement in type 2 diabetes. METHODS. This analysis was conducted as part of using baseline, cross-sectional data from a larger, prospective, controlled study of an intervention to improve care for individuals with type 2 diabetes in rural communities in Alberta, Canada. The HU12 and HUI3 were self-administered to 372 community-dwelling individuals with type 2 diabetes.
RESULTS: Relative to HUI2 scores, larger differences in overall HUI3 scores were seen for comparisons for individuals presumed to have more advanced disease. The pain attribute of the HUI3 categorized a larger proportion of individuals as moderately to severely impaired (41.5% v. 24.2%, P < 0.001), as did the emotion attribute (20.5% v. 7.7%, P < 0.001). For individuals with negative overall HUI3 scores, differences between overall HUI2 and HUI3 scores persisted after rescaling (mean difference = 0.33, P = 0.009).
CONCLUSIONS: The greater range of possible scores on the HUI3, its relative ability to assess the utility of states worse than dead, and its relative superiority in discriminating moderate to severe impairment from mild or no impairment might favor its use over the HUI2 in type 2 diabetes.

Entities:  

Mesh:

Year:  2003        PMID: 14672109     DOI: 10.1177/0272989X03258438

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  18 in total

1.  Understanding the complex associations between patient-provider relationships, self-care behaviours, and health-related quality of life in type 2 diabetes: a structural equation modeling approach.

Authors:  Sheri L Maddigan; Sumit R Majumdar; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

2.  Correlates of health-related quality of life in type 2 diabetes.

Authors:  D J Wexler; R W Grant; E Wittenberg; J L Bosch; E Cagliero; L Delahanty; M A Blais; J B Meigs
Journal:  Diabetologia       Date:  2006-04-29       Impact factor: 10.122

3.  Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey.

Authors:  Sheri L Maddigan; David H Feeny; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

4.  Understanding the determinants of health for people with type 2 diabetes.

Authors:  Sheri L Maddigan; David H Feeny; Sumit R Majumdar; Karen B Farris; Jeffrey A Johnson
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

5.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

6.  A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia.

Authors:  Nan Luo; Boon-Kheng Seng; Julian Thumboo; David Feeny; Shu-Chuen Li
Journal:  Qual Life Res       Date:  2006-06       Impact factor: 4.147

7.  Longitudinal construct validity of the Health Utilities Indices Mark 2 and Mark 3 in hip fracture.

Authors:  C Allyson Jones; Sheri L Pohar; David H Feeny; Ken Eng
Journal:  Qual Life Res       Date:  2013-10-01       Impact factor: 4.147

8.  Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens.

Authors:  Jeremy Chancellor; Samuel Aballéa; Alison Lawrence; Rob Sheldon; Sandrine Cure; Juliette Plun-Favreau; Nick Marchant
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

9.  Psychoneuroimmune implications of type 2 diabetes: redux.

Authors:  Jason C O'Connor; Daniel R Johnson; Gregory G Freund
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

Review 10.  Quality of life in glaucoma and three other chronic diseases: a systematic literature review.

Authors:  Tim Mills; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.